Product NDC: | 61314-229 |
Proprietary Name: | Levobunolol Hydrochloride |
Non Proprietary Name: | Levobunolol Hydrochloride |
Active Ingredient(s): | 5 mg/mL & nbsp; Levobunolol Hydrochloride |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 61314-229 |
Labeler Name: | Falcon Pharmaceuticals, Ltd. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074850 |
Marketing Category: | ANDA |
Start Marketing Date: | 19970130 |
Package NDC: | 61314-229-15 |
Package Description: | 15 mL in 1 BOTTLE, PLASTIC (61314-229-15) |
NDC Code | 61314-229-15 |
Proprietary Name | Levobunolol Hydrochloride |
Package Description | 15 mL in 1 BOTTLE, PLASTIC (61314-229-15) |
Product NDC | 61314-229 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Levobunolol Hydrochloride |
Dosage Form Name | SOLUTION |
Route Name | OPHTHALMIC |
Start Marketing Date | 19970130 |
Marketing Category Name | ANDA |
Labeler Name | Falcon Pharmaceuticals, Ltd. |
Substance Name | LEVOBUNOLOL HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |